Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Oct
15
2018
“Clarification” of Border Crossing Rules Raises More Questions for Canadian Cannabis Industry Wilson Elser Moskowitz Edelman & Dicker LLP
Dec
17
2018
New York Tightens Its Grip on CBD Even as the Feds Ease Industrial Hemp Restrictions Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
28
2019
New Jersey Legislature Cancels Vote to Legalize Recreational Marijuana Wilson Elser Moskowitz Edelman & Dicker LLP
Oct
24
2019
Cannabis Coming to the Northeast? Governors of NY, NJ, CT and PA adopt “core principles” to implement adult-use legislation. Wilson Elser Moskowitz Edelman & Dicker LLP
Oct
29
2019
Court Agrees Recent Ban of ALL Vaping Products in Massachusetts by Executive Order Is Violation of the Law Wilson Elser Moskowitz Edelman & Dicker LLP
Nov
5
2015
Where’s the Beef? Are Stricter Warning Label Requirements on the Horizon for the Meat Industry? Wilson Elser Moskowitz Edelman & Dicker LLP
Sep
18
2023
Report to Congress Identifies Significant Implications of Marijuana Rescheduling Wilson Elser Moskowitz Edelman & Dicker LLP
Nov
28
2017
City of Los Angeles Approves Cannabis Ordinances Wilson Elser Moskowitz Edelman & Dicker LLP
Jan
19
2018
New Rules for Cannabis: The Coming Wave of California False Advertising and Unfair Competition Claims Wilson Elser Moskowitz Edelman & Dicker LLP
Jan
25
2018
Expect Delays: Challenges Ahead for California’s Cannabis Distribution System Wilson Elser Moskowitz Edelman & Dicker LLP
May
29
2018
Never-Ending Liability Under Novartis Wilson Elser Moskowitz Edelman & Dicker LLP
Nov
15
2018
What’s up on Prop 65 Three Months after New Regulations? Wilson Elser Moskowitz Edelman & Dicker LLP
Feb
12
2019
New York City Bans CBD from Bars and Restaurants Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
29
2019
Learned Intermediary Doctrine Protects Pharmacy from Liability for Failure to Warn of Prescription Drug Side Effects Wilson Elser Moskowitz Edelman & Dicker LLP
Oct
18
2022
Cannabis and Hemp Companies Disregard Emerging Product Liability Risks at Their Peril Wilson Elser Moskowitz Edelman & Dicker LLP
Dec
21
2018
FDA Updates Its Position on CBD upon Signing of Farm Bill Wilson Elser Moskowitz Edelman & Dicker LLP
Jun
22
2022
U.S. Supreme Court Refuses to Hear Medical Cannabis Workers’ Compensation Case Wilson Elser Moskowitz Edelman & Dicker LLP
May
20
2019
California Poised to Remove Prohibition on Hemp-Derived CBD in Foods and Supplements Wilson Elser Moskowitz Edelman & Dicker LLP
Dec
1
2022
Employment Tip of the Month – December 2022 Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
24
2015
Modernizing and Coordinating the Regulatory System of Biotechnology Products Wilson Elser Moskowitz Edelman & Dicker LLP
Jan
13
2016
U.S. District Court Says No to Marijuana Industry Credit Union in Colorado Wilson Elser Moskowitz Edelman & Dicker LLP
Oct
3
2017
Cannabis Prop 65 Liability: Lessons Learned from the Dietary Supplement Industry Wilson Elser Moskowitz Edelman & Dicker LLP
May
17
2024
DOJ Confirms Moving Marijuana to Schedule III; Sidesteps Anticipated Impact on State Cannabis Markets Wilson Elser Moskowitz Edelman & Dicker LLP
May
24
2017
California’s Insurance Commissioner Encourages Admitted Carriers to Insure Cannabis Risks Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
22
2021
The SAFE Banking and CLAIM Acts Will Transform the Cannabis Insurance Industry – Here’s What to Expect Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
23
2021
Update on the Legalization of Marijuana in Connecticut Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
7
2019
Market Confusion on CBD and Hemp; FDA Commissioner Resigns amid Congressional Pressure for Federal Guidance Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
9
2019
Two Bills and a Ban Shake Up the State of Cannabis in NY Wilson Elser Moskowitz Edelman & Dicker LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins